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Abstract
Aim The long-term value of coronary artery calcium
(CAC) scanning has not been studied extensively in
symptomatic patients, but was evaluated by us in 644
consecutive patients referred for stable chest pain.
Methods We excluded patients with a history of car-
diovascular disease and with a CAC score of zero. CAC
scanning was done with a 16-row MDCT scanner.
Endpoints were: (a) overall mortality, (b) mortality
or non-fatal myocardial infarction and (c) the com-
posite of mortality, myocardial infarction or coronary
revascularisation. Revascularisations within 1 year
following CAC scanning were not considered.
Results The mean age of the 320 women and 324
men was 63 years. Follow-up was over 8 years. There
were 58 mortalities, while 22 patients suffered non-fa-
tal myocardial infarction and 24 underwent coronary
revascularisation, providing 104 combined endpoints.
Cumulative 8-year survival was 95% with CAC score
<100, 90% in patients with CAC score >100 and <400,
and 82% with CAC score ≥400 Agatston units. Risk
of mortality with a CAC score >100 and ≥400 units
was 2.6 [95% confidence interval (CI) 1.23–5.54], and
4.6 (95% CI 2.1–9.47) respectively. After correction
for clinical risk factors, CAC score remained indepen-
dently associated with increased risk of cardiac events.
Conclusions Risk increased with increasing CAC score.
Patients with CAC >100 or ≥400 Agatston units were
at increased risk of major adverse cardiac events and
are eligible for preventive measures. CAC scanning
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provided incremental prognostic information to guide
the choice of diagnostic and therapeutic options in
many subjects evaluated for chest pain.
What’s new?
The coronary artery calcium (CAC) score provides
a quantitative assessment of the overall atheroscle-
rotic burden, a measure not readily available with
other forms of testing. We studied the long-term
prognostic value of CAC scanning in a consecutive
series of 644men and womenwith stable chest pain
but without previous cardiovascular disease.
A graded relation was found between CAC score
and prognosis. The increase in risk was graded, and
thus with larger scores, the risk became higher.
Both CAC score >100 as well as ≥400 Agatston
units were associated with an increased risk of mor-
tality [relative risk (RR) 2.6, 95% confidence interval
(CI) 1.2–5.5 and RR 4.6, 95% CI 2.1–9.5, respectively]
as well as with the occurrence of other major car-
diac events. This association was not modified by
correction for type of chest pain and risk factors.
Subjects with CAC score ≥400 units, constituting
about 25% of the patients, were at highest risk with
a rate of death or myocardial infarction in the or-
der of 3% per year and would qualify for preventive
medical treatment. Subjects with a CAC score be-
tween 100 and 400 units should be considered for
primary preventive measures given their increased
mortality.
Thus, application of the CAC score provided
relevant prognostic information in addition to
the usual clinical risk characteristics in patients
suspected of coronary artery disease, and its ap-
plication could guide the subsequent choice of
diagnostic and therapeutic options in many such
subjects.
Prognostic value of the coronary artery calcium score in suspected coronary artery disease: a study of 644. . .
Original Article
Keywords Coronary artery calcium score ·
Symptomatic · Stable chest pain · Prognosis ·
Coronary artery disease
Introduction
Conventional coronary angiography is the reference
standard for the diagnosis of coronary artery disease
(CAD), but its diagnostic yield is low [1]. This is not
only true with regard to the actual diagnostic findings:
many subjects undergoing coronary angiography ex-
hibit findings that are considered normal. But the
low return is also reflected in the lack of therapeu-
tic consequences associated with the procedure. Only
about 50% of abnormal diagnostic coronary angiogra-
phies in patients with stable chest pain are followed
by revascularisation [2]. Coronary angiography using
computer tomography (CTCA) has been suggested as
an alternative and less invasive diagnostic technique.
Still, randomised studies comparing CTCA with func-
tional testing in suspected CAD found no differences
in outcomes between these two approaches [3, 4].
The detection of coronary artery calcium (CAC) by
non-contrast CT scanning could represent an alter-
native diagnostic and prognostic tool. The CAC score
provides a quantitative assessment of the overall
atherosclerotic burden, a measure not readily avail-
able with other forms of testing [5]. The CAC score has
been shown to reliably predict events among various
categories of subjects studied. Among asymptomatic
subjects, CAC scanning improved prognostic classifi-
cation [6]. In symptomatic individuals, the absence of
CAC has been shown to identify subjects at low risk
for cardiovascular disease (CVD) and cardiovascular
events, precluding the need for further downstream
testing [7].
The long-term worth of CAC scoring in patients
with symptoms suggestive of CAD has not been stud-
ied extensively [8]. We therefore investigated the prog-
nostic value of CAC scanning in a consecutive series
of 644 men and women with stable chest pain.
Methods
Patients
From December 2004 to May 2011, patients consec-
utively referred for the evaluation of their chest pain
underwent a CAC scan. Symptoms were classified as
typical, atypical or non-specific. Patients with a his-
tory of CVD were excluded. Because previous research
has shown that both the short- and long-term prog-
nosis of patients with a CAC score of zero is excellent,
such patients were excluded from the current analysis
[7, 9].
The study complied with the Declaration of Helsinki
and was approved by the local research ethics com-
mittee.
Risk factors
Hypertension was defined as systolic blood pres-
sure >140mmHg and/or diastolic blood pressure
>90mmHg, or treatment for hypertension. Dyslipi-
daemia was defined as total cholesterol >6.0mmol/l
or treatment for dyslipidaemia. Diabetes mellitus was
diagnosed when haemoglobin A1c was ≥48mmol/l,
fasting plasma glucose >7.0mmol/l, a random plasma
glucose >11mmol/l or when glucose-lowering ther-
apy was used. Smoking was self-reported. Family
history of premature CAD was defined as a history
of myocardial infarction, percutaneous coronary in-
tervention or revascularisation before age 60 years in
a first-degree family member. Pre-test likelihood was
determined on the basis of history, age and sex [10].
Calcium score
A 16-row MDCT scanner (Sensation 16 Siemens, Er-
langen, Germany) was used to acquire a volume set of
data of the heart according to standard spiral protocol.
CAC was measured by the Agatston method (Calcium
scoring, Wizard workstation, Sensation 16, Siemens).
The CAC score was classified as 0.1–100, 100–400 and
≥400 Agatston units.
Follow-up
Survival was assessed in May 2016 by use of the
national Civil Registry. Surviving patients received
a questionnaire to collect information on cardiac
events and procedures. Potential clinical events were
adjudicated after review of pertinent hospital records.
The date of the last known information from either
source was used to calculate follow-up time. Five
patients were lost to follow-up and excluded from
analysis.
Data analysis
Categorical variables are presented as absolute num-
bers and frequencies and continuous variables as
mean± SD. Endpoints included: (a) overall mortal-
ity, (b) mortality or non-fatal myocardial infarction
and (c) the composite of mortality, myocardial infarc-
tion or coronary revascularisation by either coronary
artery bypass grafting or percutaneous coronary in-
tervention. In the latter analyses, 70 early (occurring
within 1 year after inclusion) revascularisations were
censored to minimise verification bias. Log-rank tests
were used to compare different curves. The Kaplan-
Meier method was used to assess event-free survival
for outcomes of interest. Cox proportional hazard
models were employed to adjust the association of
the CAC score and adverse cardiac outcome for po-
tential confounders. SPSS software (version 24.0,
SPSS Inc., Chicago, IL, USA) was used for statistical
analyses.
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Results
Patients and follow-up
We included 644 patients, 320 women and 324 men.
Their mean age was 63 (range 35–88) years. Details of
the study population are presented in Tab. 1. Based
upon their type of chest pain, 13% of the patients had
a low, 72% an intermediate and 15% a high pre-test
likelihood of CAD. In the low pre-test likelihood group
12% of the patients showed a CAC score ≥400, com-
pared to 33% in the high pre-test likelihood group.
During a median follow-up of 8 (range 5–12) years,
58 patients died, while 22 others suffered a non-fatal
myocardial infarction. In addition, 24 patients under-
went coronary revascularisation after at least 1 year
following their first clinical examination. Thus, 104
patients experienced the combined endpoint.
Coronary artery calcium scoring and prognosis
In 261 (41%) patients, the CAC score was between
0.1 and 100. A CAC score between 100 and 400 was
found in 217 (34%) patients, and the CAC score was
≥400 Agatston units in 166 (26%) patients.
Cumulative 8-year survival rate was 95% in patients
with a low (<100) CAC score, 90% in patients with
a CAC score between 100 and 400, and 82% in pa-
tients with a high (400 units or higher) CAC score.
The survival of patients with a CAC score ≥400 was
significantly (p<0.01) lower than that of subjects with
a lower score. The rate of the combined fatal and non-
Table 1 Baseline patient characteristics and clinical as-
sessment
Characteristic Males Females Total
Gender (%) 324 (50) 320 (49) 644 (100)
Age, years 61 (11) 65 (10) 63 (11)
Body mass index, kg/m2 27 (4) 27 (4) 27 (4)
Current smoker (%) 67 (21) 40 (13) 107 (17)
Diabetes (%) 55 (17) 58 (19) 113 (18)
Family history of CAD (%) 137 (42) 150 (47) 287 (45)
Systolic BP, mmHg 142 (19) 143 (20) 143 (20)
Hypertension (%) 142 (44) 164 (51) 306 (47)
Cholesterol, mmol/l 5.4 (1.2) 5.7 (1.3) 5.6 (1.2)
Dyslipidaemia (%) 84 (26) 94 (29) 178 (28)
Type of chest pain (%)
non-anginal 160 (50) 157 (49) 317 (49)
atypical 88 (27) 120 (38) 208 (32)
typical 76 (23) 43 (13) 119 (18)
CAC score, Agatston units
>0.1–100 (%) 116 (36) 146 (46) 262 (41)
100–400 (%) 109 (34) 107 (33) 216 (34)
≥400 (%) 99 (31) 67 (21) 166 (26)
Data are n (%) or mean± SD
CAD coronary artery disease; BP blood pressure; CAC coronary artery
calcium
fatal events between the three groups of patients with
varying degrees of coronary calcification was clinically
relevant and statistically significantly different (Fig. 1).
In univariate analysis, a graded relation between
CAC score and prognosis was found. Both CAC score
>100 and ≥400 units were associated with increased
risk of mortality [relative risk (RR) 2.6, 95% confidence
interval (CI) 1.2–5.5 and RR 4.6, 95% CI 2.1–9.5, re-
spectively] as well as with the occurrence of other
cardiac events (Tab. 2). After correction for type of
chest pain and risk factors, the associations between
elevated CAC score and adverse events remained sta-
tistically significant for the combined endpoint. Other
parameters associated with increased risk included
higher age, male sex and positive family history of
CAD.
Discussion
Application of the CAC score provided relevant prog-
nostic information in addition to the usual clinical risk
characteristics in these men and women suspected of
CAD. Increased risk was apparent from a CAC score
of 100 Agatston units upwards. The increase in risk
was graded; thus with larger scores the risk became
higher. Subjects with a CAC score ≥400 units, consti-
tuting about 25% of the patients, were at highest risk
with a rate of death or myocardial infarction in the
order of 3% per year.
Although early establishment of a definitive anatom-
ical diagnosis in subjects with chest pain seems de-
sirable, two recent trials were unable to establish the
benefit of such an approach. For instance, the Scottish
Computed Tomography of the Heart (SCOT-HEART)
trial, a study of low to intermediate risk patients, in-
vestigated the diagnostic value of CTCA [4]. The over-
all prevalence of obstructive CAD was 25%. Although
CTCA changed the diagnosis of angina pectoris in
27% of the participants, altered recommendations for
treatment in 18% as well as antianginal therapy in 9%
(compared to 1% in the participants assigned to con-
ventional clinical care), this was insufficient to lower
the frequency and severity of symptoms or reduce the
incidence of cardiac events. Diagnostic evaluations
in the control group included stress electrocardiog-
raphy (in 85%) and radionuclide stress imaging (in
10%). In the Prospective Multicenter Imaging Study
for Evaluation of Chest Pain (PROMISE) trial, CTCA
was not superior to functional testing, including nu-
clear stress imaging in 67%, stress echocardiography
in 23% and exercise testing in 10% [3]. The results of
these two large studies temper the over-enthusiastic
use of CTCA as well as coronary angiography in the
general screening of patients with chest pain. Such
testing could perhaps be appropriate in specific sub-
groups of patients, but such categories have not yet
been identified.
In patients with chest pain at intermediate risk, ad-
ditional tests are often necessary to arrive at a robust
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diagnostic classification. Coronary angiography will
be the method of ultimate choice in many. How-
ever, even the diagnostic use of coronary angiogra-
phy has been found to be of limited clinical benefit
Fig. 1 a–c Eight-year cu-
mulative survival accord-
ing to coronary artery cal-
cium score categories.
a Event-free survival mor-
tality; b mortality and non-
fatal myocardial infarc-
tion; c mortality, non-
fatal infarction and (late)
coronary revascularisation.
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[11]. Importantly, the difference between significant
versus minor obstructive CAD is not straightforward
and often fraught with uncertainty [12]. While coro-
nary angiography may contribute in the identification
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Table 2 Unadjusted and adjusted association of coro-
nary artery calcium score and adverse cardiac outcomes
Parameter Univariate analysis Multivariate analysis
Mortality
n= 58
Calcium score RR 95% CI RR 95% CI
0.1–100 Ref Ref
100–400 2.61 1.23–5.54 1.76 0.82–3.78
≥400 4.56 2.10–9.47 2.08 0.96–4.51
Mortality and MI
n= 80
Calcium score RR 95% CI RR 95% CI
0.1–100 Ref Ref
100–400 2.41 1.29–4.50 1.79 0.95–3.37
≥400 4.15 2.26–7.60 2.31 1.22–4.41
Mortality, MI, late revascularisation
n= 104
Calcium score RR 95% CI RR 95% CI
0.1–100 Ref Ref
100–400 2.06 1.22–3.48 1.76 1.03–2.99
≥400 4.49 2.71–7.45 2.80 1.80–5.37
RR relative risk; C confidence interval; MI myocardial infarction
of stable CAD, many stenoses thus identified may not
be functionally significant. Evidence that either sur-
gical or percutaneous coronary intervention improves
the prognosis of unselected patients with stable chest
pain without previous CVD is lacking [13].
Data about the effect of statin treatment on prog-
nosis in subjects with high CAC scores are not con-
clusive. Arad et al. evaluated the treatment of 1005
asymptomatic subjects with CAC scores above the
80th percentile with atorvastatin 20mg and antiox-
idant vitamins. In patients with CAC scores >400
a trend towards reduction of cardiovascular events
was observed but did not achieve statistical signifi-
cance [14]. A large observational study by Mitchell
et al. showed that an increasing severity of CAC was
associated with increased benefit from statin treat-
ment for the prevention of major adverse cardiac
events (MACE) with the greatest benefit in subjects
with a CAC score >100. The estimated 10-year number
needed to treat (NNT) for MACE for a CAC score >100
was 12 [15]. However, substantial differences between
the statin and no statin group existed in CAC score
and additional medication. Therefore, confounding
could not be completely ruled out. In the Multi-
Ethnic Study of Atherosclerosis (MESA) by Mortensen
et al. mathematical models estimated the 10-year
NNT for MACE for CAC score >100 as 28 assuming
a 30% relative risk reduction with statin therapy [16].
Prospective randomised studies that can show the
risk and benefit in CVD risk stratification based on
CAC scoring, like the ongoing ROBINSCA trial, are
very much needed [17].
The optimal strategy in suspected CAD therefore
remains somewhat nebulous. Instead of establish-
ing a diagnosis, prognostic evaluation of patients with
suspected CAD surely considers merit. To this end,
the exercise test has many proponents. The response
to exercise provides a physiological measure of car-
diac function at low cost. The Duke treadmill score,
combining workload, angina and ischaemia into one
numerical score, was found to add independent prog-
nostic information to the clinical assessment in pa-
tients with suspected CAD [18]. However, the diagnos-
tic employment of exercise testing in clinical practice
is not uniform [3] and is given relatively low priority
in the European guidelines [19].
The non-invasive detection of CAC is sensitive for
the presence of significant CAD, and may be a useful
adjunct in both diagnostic and prognostic work-up
of patients with chest pain [20]. CAC is a continu-
ous variable with increasing specificity with higher
calcium scores indicating more severe atherosclerotic
disease. However, while widely used for risk strati-
fication and management guiding in asymptomatic
individuals, the diagnostic and prognostic use of CAC
scanning in patients with symptoms suggestive of
CAD has been less extensively studied. Nevertheless,
CAC scanning in conjunction with a clinically derived
pre-test probability has been shown to reliably predict
angiographic disease non-invasively [21].
In the evaluation of the additive prognostic per-
formance of CAC score over CTCA, both CTCA per-
cent stenosis and CAC were independently associated
with increased incidences ofMACE, while the addition
of the CAC score to the model with clinical risk fac-
tors and CT stenosis improved predictive performance
[22]. From a biological standpoint, the additive prog-
nostic value of CAC over CCTA stenosis is not surpris-
ing. These techniques measure different aspects of
CAD. CAC reflects calcified plaque burden, shown to
be closely related to total coronary atherosclerotic de-
velopment, whereas CTCA and coronary angiography
focus on localised coronary luminal stenosis. A strong
relationship has been established between CAC find-
ings and coronary flow reserve. Increased frequency
of coronary flow reduction was noted in patients with
a CAC score ≥400 [23]. Such findings are support-
ive of a greater likelihood of important physiological
changes with increasing anatomic atherosclerotic bur-
den, assessed by the CAC score.
The incidence of true stable angina pectoris in
symptomatic patients without a history of CVD is
low [24]. Only a minority of men and women re-
ferred for evaluation of chest pain has angina pectoris
resulting from obstructive CAD, and the low preva-
lence of significant CAD in patients with chest pain
has been confirmed in many recent studies. For in-
stance, significant CAD in the SCOT-HEART trial was
present in only 25% [4]. In the PROMISE trial [3], only
about 11% of all patients tested initially as ‘positive
for CAD’. Among almost 400,000 patients undergoing
elective coronary angiography following initial non-
invasive examination, only 37% had obstructive CAD
[1]. These findings illustrate the need for more effi-
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cient testing and better risk stratification of patients
with chest pain. CAC scanning could well represent
a useful initial test for this purpose, as additional tests
are no longer needed in patients with either very low
or very high CAC scores. In the recent prospective
PROMISE trial [3], most patients experiencing clinical
events presented with positive CAC scans, while less
than half had functional stress test abnormalities.
Although the abnormal functional test was more spe-
cific for CVD events, the discriminatory ability of CAC
scanning proved to be a useful adjunct in the initial
evaluation of patients with chest pain [25].
Study limitations
By nature of the population studied, the number of
fatal events in our study was quite small, and could
have affected the power of the associations. In ad-
dition, the CAC score could have modified the diag-
nostic path, since an abnormal scan could have per-
suaded the physician to opt for coronary angiography
and coronary revascularisation. However, this verifi-
cation bias would have impacted mainly on the initial
clinical course, and early coronary interventions were
excluded from the current analysis. We did not inves-
tigate the effect of CAC scoring on downstream change
of medication. This could have influenced outcome.
In view of the favourable prognosis of patients with
a CAC score of 0, these were excluded. Their inclusion
would have increased the risk association of higher
CAC scores with subsequent adverse cardiac events.
Conclusion
In summary, in this study of 644 consecutive patients,
CAC scanning provided significant incremental infor-
mation on their 8-year prognosis. Patients with a CAC
score <100 units had a favourable prognosis. Both pa-
tients with a CAC score >100 or ≥400 Agatston units
had increased risk of MACE and are eligible for pre-
ventive measures. Thus, CAC scanning provided in-
cremental prognostic information and could guide the
subsequent choice of diagnostic and therapeutic op-
tions in many subjects evaluated for chest pain.
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